Oruka Therapeutics, Inc. Diluted Shares Outstanding (Weighted Average)
Oruka Therapeutics, Inc. (ORKA) reported Diluted Shares Outstanding (Weighted Average) of 42.10 million shares for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2025-08-11
- Oruka Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 42.10M shares, a 1216.33% increase year-over-year.
- Oruka Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 41.68M shares, a 187.42% increase year-over-year.
- Oruka Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 15.01M shares, a 4.19% increase year-over-year.
- Oruka Therapeutics, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-06-30 was 3.20M shares, a 77.81% decline year-over-year.
- Oruka Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 14.42M shares, a 0.04% increase from fiscal 2022.
- Oruka Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 14.41M shares, a 3.64% increase from fiscal 2021.
- Oruka Therapeutics, Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 13.90M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 2 month | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 5 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 8 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 11 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 42.10M shares 10-Q · filed 2025-08-11 | 41.89M shares 10-Q · filed 2025-08-11 | |||||||
| 2025-03-31 | 41.68M shares 10-Q · filed 2025-05-14 | ||||||||
| 2024-12-31 | 16.79M shares 10-K · filed 2025-03-06 | ||||||||
| 2024-09-30 | 15.01M shares 10-Q · filed 2024-11-13 | 9.11M shares derived: average of 2 quarters · filed 2025-08-11 | 7.77M shares 10-Q · filed 2024-11-13 | 10.90M shares derived: average of 3 quarters · filed 2025-08-11 | 11.79M shares derived: average of 4 quarters · filed 2025-08-11 | ||||
| 2024-06-30 | 3.20M shares 10-Q · filed 2025-08-11 | 14.51M shares 10-Q · filed 2024-08-01 | 3.20M shares 10-Q · filed 2025-08-11 | 14.50M shares 10-Q · filed 2024-08-01 | 10.71M shares derived: average of 3 quarters · filed 2025-08-11 | 11.64M shares derived: average of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | 3.20M shares 10-Q · filed 2025-05-14 | 14.50M shares 10-Q · filed 2024-04-25 | 14.47M shares derived: average of 2 quarters · filed 2024-04-25 | 14.45M shares derived: average of 3 quarters · filed 2024-04-25 | 14.44M shares derived: average of 4 quarters · filed 2024-08-01 | ||||
| 2023-12-31 | 14.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | 14.42M shares derived: average of 2 quarters · filed 2024-02-01 | 14.42M shares derived: average of 3 quarters · filed 2024-08-01 | 14.42M shares 10-K · filed 2024-02-01 | |||||
| 2023-09-30 | 14.41M shares 10-Q · filed 2023-10-18 | 14.41M shares derived: average of 2 quarters · filed 2024-08-01 | 14.41M shares 10-Q · filed 2023-10-18 | 14.41M shares derived: average of 4 quarters · filed 2024-08-01 | |||||
| 2023-06-30 | 14.41M shares 10-Q · filed 2024-08-01 | 14.41M shares 10-Q · filed 2024-08-01 | 14.41M shares derived: average of 3 quarters · filed 2024-08-01 | 14.41M shares derived: average of 4 quarters · filed 2024-08-01 | |||||
| 2023-03-31 | 14.41M shares 10-Q · filed 2024-04-25 | 14.41M shares derived: average of 2 quarters · filed 2024-04-25 | 14.41M shares derived: average of 3 quarters · filed 2024-04-25 | 14.41M shares derived: average of 4 quarters · filed 2024-04-25 | |||||
| 2022-12-31 | 14.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | 14.41M shares derived: average of 2 quarters · filed 2024-02-01 | 14.41M shares derived: average of 3 quarters · filed 2024-02-01 | 14.41M shares 10-K · filed 2024-02-01 | |||||
| 2022-09-30 | 14.41M shares 10-Q · filed 2023-10-18 | 14.41M shares derived: average of 2 quarters · filed 2023-10-18 | 14.41M shares 10-Q · filed 2023-10-18 | 14.41M shares derived: average of 4 quarters · filed 2023-10-18 | |||||
| 2022-06-30 | 14.41M shares 10-Q · filed 2023-07-21 | 14.41M shares 10-Q · filed 2023-07-21 | 14.41M shares derived: average of 3 quarters · filed 2023-07-21 | 14.41M shares derived: average of 4 quarters · filed 2023-07-21 | |||||
| 2022-03-31 | 14.41M shares 10-Q · filed 2023-04-24 | 14.41M shares derived: average of 2 quarters · filed 2023-04-24 | 14.41M shares derived: average of 3 quarters · filed 2023-04-24 | 14.41M shares derived: average of 4 quarters · filed 2023-04-24 | |||||
| 2021-12-31 | 14.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | 14.41M shares derived: average of 2 quarters · filed 2023-02-24 | 14.41M shares derived: average of 3 quarters · filed 2023-02-24 | 13.90M shares 10-K · filed 2023-02-24 | |||||
| 2021-09-30 | 14.41M shares 10-Q · filed 2022-10-28 | 14.41M shares derived: average of 2 quarters · filed 2022-10-28 | 13.73M shares 10-Q · filed 2022-10-28 | ||||||
| 2021-06-30 | 14.41M shares 10-Q · filed 2022-08-02 | 13.39M shares 10-Q · filed 2022-08-02 | |||||||
| 2012-06-30 | 12.17M shares 10-Q · filed 2012-08-13 | 12.17M shares 10-Q · filed 2012-08-13 | |||||||
| 2011-06-30 | 10.25M shares 10-Q · filed 2012-08-13 | 9.48M shares 10-Q · filed 2012-08-13 | |||||||
| 2010-06-30 | 8.73M shares 10-Q · filed 2011-08-15 | 8.19M shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |